Beyond GLP-1 Receptor Agonists: Examining Innovative Mechanisms of Action & Clinical Data for the Treatment of Obesity

Time: 11:30 am
day: Day 1 Stream 1 AM


  • From GLP-1 monotherapy to triple agonists: enhancing effective drug-based therapy for weight loss to rival bariatric surgery
  • Exploring advances in dual receptor agonists, triple receptor agonists and combination therapies for the treatment of obesity, NASH, and metabolic dysfunction
  • Assessing the comparative benefits of different agents and mechanisms of action in these conditions